Keurig Dr Pepper is a leading beverage company that specializes in the production and distribution of a diverse portfolio of soft drinks, flavored waters, and coffee products
With a strong emphasis on convenience, the company is well-known for its innovative single-serve coffee machines and a wide array of beverage brands, catering to various consumer preferences. The company's offerings include both popular national brands and niche products, reflecting its commitment to meeting the evolving tastes of consumers across different markets. Additionally, Keurig Dr Pepper focuses on sustainability initiatives, aiming to reduce environmental impact while enhancing the overall customer experience through its products and services.
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Keurig Dr Pepper (NASDAQKDP) and its peers.
Keurig Dr Pepper currently trades at $30.68 per share and has shown little upside over the past six months, posting a small loss of 5%. The stock also fell short of the S&P 500’s 6.3% gain during that period.
Piper Sandler analyst Mike Lavery initiated coverage on Keurig Dr Pepper with a Neutral rating and a $35 target price, citing challenges in its coffee segment due to rising coffee bean costs.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how beverages, alcohol, and tobacco stocks fared in Q3, starting with Altria (NYSEMO).
Over the last six months, Keurig Dr Pepper’s shares have sunk to $32.08, producing a disappointing 5.5% loss - a stark contrast to the S&P 500’s 11.1% gain. This may have investors wondering how to approach the situation.
Looking back on beverages, alcohol and tobacco stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Tilray Brands (NASDAQTLRY) and its peers.
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Molson Coors (NYSETAP) and its peers.
Monster Beverage is a scary good buy with shares at near a long-term low, sitting on a strong support target, with growth and acceleration in 2025 expected.
Will buying Celsius stock today be a game-changer for your portfolio in the long run? Let's weigh this exciting energy drink specialist's upsides and downsides.
Keurig Dr Pepper Inc. (NASDAQKDP) shares are trading lower Tuesday after the company announced the pricing of a secondary offering. Here's what you need to know.
